Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 1,021-1,032 of 9,138
Device study icon
RecruitingNCT05855421

Auricular Acupuncture for depression

This study is recruiting in Brazil. It is testing auricular Acupuncture for depression.

Depression, AnxietyDeviceFrom 18 Years to 50 Years
Countries
Brazil
Sponsor
Universidade do Sul de Santa Catarina
Condition
Depression, Anxiety
Other study type icon
RecruitingNCT06540664

Auricular Acupuncture for Depression

This study is recruiting in Vietnam. It is testing auricular Acupuncture for Depression.

DepressionOtherOver 18 Years
Countries
Vietnam
Sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Condition
Depression
Drug study icon
Not Yet RecruitingNCT02129751

Bupropion Hydrobromide for depression

This study is not yet recruiting in Global. It is testing bupropion Hydrobromide for depression.

DepressionDrugFrom 7 Years to 17 Years
Countries
Global
Sponsor
Bausch Health Americas, Inc.
Condition
Depression
Device study icon
RecruitingNCT06728280

DTMS for depression

This study is recruiting in China. It is testing DTMS for depression.

DepressionDeviceFrom 11 Years to 23 Years
Countries
China
Sponsor
Zhifen Liu
Condition
Depression
Other study type icon
Not Yet RecruitingNCT07331987

Probiotics for depression

This study is not yet recruiting in China. It is testing probiotics for depression.

Depression, AnxietyOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Moon (Guangzhou) Biotechnology Co., Ltd.
Condition
Depression, Anxiety
Drug study icon
UnknownNCT06270433

Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression

This study has public registry information in China. It is testing Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Jiangsu Province Nanjing Brain Hospital
Condition
Depression
Mental Health | Clinical Trials | HopeStage Research